Esperion Therapeutics, Inc. Receives Environmental Assessment and Finding of No Significant Impact for License Termination

Summary

Esperion Therapeutics, Inc., a biopharmaceutical company based in Ann Arbor, MI, has received a notice from the relevant authorities regarding the availability of an environmental assessment and a finding of no significant impact for the termination of its license. This decision allows the company to proceed with the license termination process.